Academic Journal
Quartile not availableBritish Journal of Urology
About British Journal of Urology
About British Journal of Urology
British Journal of Urology is a peer-reviewed scholarly journal published by Wiley.
Key indicators: ISSN 14644096, 1464410X.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
Publishing in British Journal of Urology
When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of British Journal of Urology?
14644096, 1464410X.
Who publishes British Journal of Urology?
Wiley.
Where do I submit to British Journal of Urology?
Via the official website.
Is British Journal of Urology peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Journal Metrics
A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Reply to: Comment on the BICEP classification for bladder injury during AEEP
Selim Soyturk, Selcuk Guven
2026-10-14 · DOI: 10.1111/bju.70457[ 18 F] fluorodeoxyglucose PET/CT refines staging and treatment selection in high‐risk upper tract urothelial carcinoma
Renee A. G. Lijnen, Joanneke B. Ringia, Kees Hendricksen, Wouter V. Vogel et al.
2026-10-13 · DOI: 10.1111/bju.70483The BICEP classification for bladder injury during endoscopic enucleation of the prostate: considerations for clinical application
Ranil Johann Boaz, Max Johnston, James Brewin, Helen Teixeira et al.
2026-10-13 · DOI: 10.1111/bju.70456Transurethral ultrasound ablation ( TULSA ) for prostate cancer: a systematic review and meta‐analysis
Eugene Wang, Xinyi Wei, Yajat Dua, Marlon Perera et al.
2026-10-12 · DOI: 10.1111/bju.70471Surgical waiting times in patients with high‐ and low‐risk renal cell carcinoma in England
Raghav Varma, Emily Mayne, Will Cuningham, Marina A. Parry et al.
2026-10-11 · DOI: 10.1111/bju.70490Issue Information
2026-11 · DOI: 10.1111/bju.70477Prognostic biomarkers in non‐muscle‐invasive bladder cancer: biological basis and evidence
Jinghong Wang, Yitao Zhao, Yushan Ye, Xiaolong Qi et al.
2026-10-11 · DOI: 10.1111/bju.70488Recent advances in the management of prostate cancer
2026-11 · DOI: 10.1111/bju.70476Comparative accuracy of imaging modalities for differentiating malignant small testicular masses
Yajat Dua, Anusha Maheshwari, Marlon Perera, Declan Murphy et al.
2026-10-10 · DOI: 10.1111/bju.70492Long‐term outcomes of augmentation cystoplasty for neurogenic lower urinary tract dysfunction after spinal cord injury
Ioannis Tsikopoulos, Sarah Knight, Marc A. Furrer, Thomas M. Kessler et al.
2026-10-09 · DOI: 10.1111/bju.70464A novel ureteric stent coating reduces encrustation and improves tolerability in a randomised trial
Nikita Vistunov, Ionel Valentin Popeneciu, Wolfgang Kram, Oliver Hakenberg et al.
2026-10-09 · DOI: 10.1111/bju.70487Fracture risk and initiation of bone‐specific drug therapy following radical cystectomy with urinary diversion
Mieke Van Hemelrijck, Lars Holmberg, Hans Garmo, Truls Gårdmark et al.
2026-10-08 · DOI: 10.1111/bju.70472Robotic left renal vein transposition for nutcracker syndrome: side‐clamp to tailored reconstruction
Jinbin Xu, Zifeng Xu, Zhansen Huang, Qunxiong Huang et al.
2026-10-08 · DOI: 10.1111/bju.70482Active surveillance for prostate cancer: evidence interpretation and research priorities
Takeshi Takahashi
2026-10-08 · DOI: 10.1111/bju.70486Improved survival in newly diagnosed metastatic prostate cancer: a National Prostate Cancer Audit study
Arjun Nathan, Matthew G. Parry, Emily Mayne, Adrian Cook et al.
2026-10-08 · DOI: 10.1111/bju.70432Aquablation as salvage therapy for benign prostatic hyperplasia: an international multicentre study
Anouk Leathead, Nick Lee, Adel Arezki, David Bouhadana et al.
2026-10-07 · DOI: 10.1111/bju.70481ManUSPECTRAL – the Mannheim Urology HyperSPECTRAL Imaging Atlas of 17 Physiological Human Organs
Alexander Rathenborg, Vera Klütz, Paula Grützner, Luisa Hartung et al.
2026-10-07 · DOI: 10.1111/bju.70467Artificial Intelligence ( AI) ‐enhanced journal club: integrating podcasts, AI , and social media in medical education
Mohamed Abouelenein, Muhammed Arif Ibis, Molly Nichols, Azhar Khan et al.
2026-10-06 · DOI: 10.1111/bju.70479Testosterone breakthrough and outcomes during intensified therapy in metastatic hormone‐sensitive prostate cancer: the ARASENS and LATITUDE trials
Xiyue Xiao, Xudong Ni, Yufan Zhao, Xiaomeng Li et al.
2026-10-05 · DOI: 10.1111/bju.70474Reviews
Community Reviews
Version History
October 10, 2026 at 4:57 pm
October 9, 2026